KAYIKÇIOĞLU, E.; ONDER, A. H. . The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors. Chronicles of Precision Medical Researchers, [S. l.], v. 3, n. 3, 2022. DOI: 10.5281/zenodo.7195780. Disponível em: https://chronpmr.com/index.php/cpmr/article/view/145-149. Acesso em: 3 feb. 2023.